Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Journal of Medical Genetics
|
June 23, 2009
Penetrance of marked cognitive impairment in older male carriers of the FMR1 gene premutation
M Sévin, Z Kutalik, S Bergman, et al.
Advances in Neurology
|
November 22, 2002
Parkinson's disease is a neuropsychiatric disorder
Y Agid, I Arnulf, P Bejjani, et al.
Revue Neurologique
|
February 24, 2026
Simulated shared and supported decision making for amyloid immunotherapy in Alzheimer's disease: A bicentric study
E Burry, F Plumacker, N Villain, et al.
Revue Neurologique
|
May 17, 2024
French guidelines for the diagnosis and management of Tourette syndrome
A Hartmann, S Ansquer, C Brefel-Courbon, et al.
European Journal of Neurology
|
September 30, 2017
High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study
G Villafane, C Thiriez, E Audureau, et al.
Journal of Medical Genetics
|
April 10, 2009
Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease
S Lesage, C Condroyer, A Lannuzel, et al.
Journal of Medical Genetics
|
October 18, 2005
Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes
S Tezenas du Montcel, F Clot, M Vidailhet, et al.
Neurology
|
March 26, 2008
Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations
E Roze, E Apartis, F Clot, et al.
The New England Journal of Medicine
|
February 15, 2013
Neurostimulation for Parkinson's disease with early motor complications
W M M Schuepbach, J Rau, K Knudsen, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Journal of Medical Genetics
|
June 23, 2009
Penetrance of marked cognitive impairment in older male carriers of the FMR1 gene premutation
M Sévin, Z Kutalik, S Bergman, et al.
Advances in Neurology
|
November 22, 2002
Parkinson's disease is a neuropsychiatric disorder
Y Agid, I Arnulf, P Bejjani, et al.
Revue Neurologique
|
February 24, 2026
Simulated shared and supported decision making for amyloid immunotherapy in Alzheimer's disease: A bicentric study
E Burry, F Plumacker, N Villain, et al.
Revue Neurologique
|
May 17, 2024
French guidelines for the diagnosis and management of Tourette syndrome
A Hartmann, S Ansquer, C Brefel-Courbon, et al.
European Journal of Neurology
|
September 30, 2017
High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study
G Villafane, C Thiriez, E Audureau, et al.
Journal of Medical Genetics
|
April 10, 2009
Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease
S Lesage, C Condroyer, A Lannuzel, et al.
Journal of Medical Genetics
|
October 18, 2005
Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes
S Tezenas du Montcel, F Clot, M Vidailhet, et al.
Neurology
|
March 26, 2008
Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations
E Roze, E Apartis, F Clot, et al.
The New England Journal of Medicine
|
February 15, 2013
Neurostimulation for Parkinson's disease with early motor complications
W M M Schuepbach, J Rau, K Knudsen, et al.
Page
of 7